Francisco Jorquera

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

RETRACTED: Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line

Javier Martín‐Renedo, José L. Mauriz, Francisco Jorquera et al. · Journal of Pineal Research · 2008 · 197 citations · Full text

Chemoprevention Strategy, Apoptosis, Cell Death +18

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

José Luís Calleja, Javier Crespo, Diego Rincón et al. · Journal of Hepatology · 2017 · 187 citations

Direct-acting Antiviral Therapy, Viral Hepatitis, Antiviral Drug Development +10

Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis

Javier Ampuero, Raluca Pais, R. Aller et al. · Clinical Gastroenterology and Hepatology · 2019 · 174 citations · Full text

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +13

Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

Camilla Stephens, Mercedes Robles‐Díaz, Inmaculada Medina‐Cáliz et al. · Journal of Hepatology · 2021 · 135 citations · Full text